Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous studies have shown that certain glycosphingolipids may function as modulators of
protein kinase C
(
PKC
) activity. To study the structure-activity relationship, we examined the effects of 17 gangliosides, 10 neutral glycolipids, as well as sulfatide, psychosine and ceramide on
PKC
activity in PC12D cells. Using an in vitro assay system, we found that all but one (GQ1b) ganglioside inhibited
PKC
activity at concentrations between 25 and 100 &mgr;M, and the potency was proportional to the number of sialic acid residues. However, at lower concentrations several gangliosides, including GM1 and LM1 behaved as mild activators of
PKC
activity. GQ1b had no effect within the range 0.1-10 &mgr;M, but acted as a mild activator of
PKC
activity at 25 &mgr;M. On the other hand, fucosyl-GM1 and GM1 containing blood group B determinant, which are abundant in PC12 cells, were potent inhibitors of
PKC
activity. Among the neutral glycosphingolipids tested, LacCer, Gb3, GalGb3, and GA1, all of which have a terminal galactose residue, were found to be ineffective or acted as mild activators of
PKC
activity. In contrast,
GA2
, Gb4 and Gb5 which have a terminal N-acetylgalactosamine residue, were potent inhibitors of the
PKC
activity. Thus, the terminal sugar residue may play a pivotal role in determining the effect of glycosphingolipids in modulating
PKC
activity. In addition, we also found that GalCer containing normal fatty acids acted as potent activators of
PKC
activity. Ceramide and GlcCer appeared to be ineffective in modulating
PKC
activity, wheras psychosine and sulfatides appeared to be inhibitory. We conclude that the carbohydrate head groups and the hydrophobic groups of gangliosides and neutral glycolipids may modulate the
PKC
system in unique manners, which may in turn affect various biological processes in the cell. Copyright 1994 S. Karger AG, Basel
...
PMID:Differential Effects of Glycosphingolipids n Protein Kinase C Activity in PC12D Pheochromocytoma Cells. 1172 31